Method comparison of beta‐hydroxybutyrate point‐of‐care testing to serum in healthy children
Abstract Ketone production is a physiological phenomenon that occurs to avoid irreversible neurological damage from hypoglycemia, thereby serving as a marker of metabolic stress. The primary ketone body, beta‐hydroxybutyrate (BHB), guides the diagnostic evaluation and management of many hypoglycemic...
Guardado en:
Autores principales: | Komalben Parmar, Maua Mosha, David A. Weinstein, Rebecca Riba‐Wolman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/284e2d5fcf3746a48d384b3fe11af57a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ketotic hypoglycemia in patients with Down syndrome
por: Danielle Drachmann, et al.
Publicado: (2021) -
β-Hydroxybutyrate Oxidation in Exercise Is Impaired by Low-Carbohydrate and High-Fat Availability
por: David J. Dearlove, et al.
Publicado: (2021) -
Evaluation of the Association of CGM Metrics with Antihyperglycemic Drugs in Insulin-Treated Diabetics
por: Toshiyuki Horiuchi, et al.
Publicado: (2021) -
Diabetic Retinopathy and Insulin Insufficiency: Beta Cell Replacement as a Strategy to Prevent Blindness
por: Eli Ipp
Publicado: (2021) -
Case Report: Insulinoma Presenting as Excessive Daytime Somnolence
por: Zhennan Yu, et al.
Publicado: (2021)